David A. Siegel A Tyr Pharma Inc Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 95,850 shares of LIFE stock, worth $178,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,850

Previous 142,350 32.67%

Holding current value

$178,281

Previous $277,000 46.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.0 - $2.07 $0 - $96,254	-46,500 Reduced 32.67%	95,850 $149,000
Q1 2024 May 15, 2024	SELL	$1.42 - $2.02 $7,668 - $10,908	-5,400 Reduced 3.65%	142,350 $277,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $1.51 $46,065 - $62,665	-41,500 Reduced 21.93%	147,750 $208,000
Q3 2023 Nov 14, 2023	SELL	$1.55 - $2.23 $293,880 - $422,808	-189,600 Reduced 50.05%	189,250 $299,000
Q2 2023 Aug 14, 2023	BUY	$1.72 - $2.57 $387,688 - $579,278	225,400 Added 146.89%	378,850 $818,000
Q1 2023 May 15, 2023	SELL	$1.88 - $2.5 $5,076 - $6,750	-2,700 Reduced 1.73%	153,450 $322,000
Q4 2022 Feb 14, 2023	SELL	$2.02 - $2.49 $54,540 - $67,230	-27,000 Reduced 14.74%	156,150 $341,000
Q3 2022 Nov 14, 2022	SELL	$2.79 - $4.15 $2,232 - $3,320	-800 Reduced 0.43%	183,150 $549,000
Q2 2022 Aug 15, 2022	SELL	$2.63 - $5.61 $35,768 - $76,296	-13,600 Reduced 6.88%	183,950 $521,000
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $901,559 - $1.43 Million	-189,802 Reduced 49.0%	197,550 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $693,264 - $903,431	-95,098 Reduced 19.71%	387,352 $2.89 Million
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $1.53 Million - $4.52 Million	362,500 Added 302.21%	482,450 $4.38 Million
Q2 2021 Aug 16, 2021	BUY	$3.62 - $4.88 $383,177 - $516,548	105,850 Added 750.71%	119,950 $585,000
Q1 2021 May 17, 2021	SELL	$3.53 - $8.06 $250,100 - $571,051	-70,850 Reduced 83.4%	14,100 $63,000
Q4 2020 Feb 16, 2021	SELL	$3.07 - $4.66 $255,731 - $388,178	-83,300 Reduced 49.51%	84,950 $330,000
Q3 2020 Nov 16, 2020	BUY	$3.23 - $5.39 $281,979 - $470,547	87,300 Added 107.84%	168,250 $543,000
Q2 2020 Aug 14, 2020	BUY	$2.55 - $4.58 $113,729 - $204,268	44,600 Added 122.7%	80,950 $359,000
Q1 2020 May 15, 2020	BUY	$2.17 - $7.06 $78,879 - $256,631	36,350 New	36,350 $102,000

Others Institutions Holding LIFE

# of Institutions

Shares Held

38.4M

Call Options Held

200

Put Options Held

4.6K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account